Skip to main content

TSR3 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-86018

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-86018-0.1ml

Key Product Details

Species Reactivity

Validated:

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Summary for TSR3 Antibody

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of Human TSR3. Peptide sequence: FGNPNRPVASTRLPSDTDDSDASEDPGPGAERGGASSSCCEEEQTQGRGA The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for TSR3 Antibody

Western Blot: TSR3 Antibody [NBP2-86018]

Western Blot: TSR3 Antibody [NBP2-86018]

Western Blot: TSR3 Antibody [NBP2-86018] - Host: Rabbit. Target Name: TSR3. Sample Type: HT1080 Whole Cell lysates. Antibody Dilution: 1.0ug/ml

Applications for TSR3 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: TSR3

Alternate Names

C16orf42, chromosome 16 open reading frame 42, MGC24381

Gene Symbol

TSR3

Additional TSR3 Products

Product Documents for TSR3 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for TSR3 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...